Drug details

Tavneos (avacopan capsules)

type of Immunosuppressants, Complement Inhibitors

Tavneos (avacopan) is a complement 5a receptor (C5aR) antagonist indicated as an adjunctive treatment of adult patients with severe active anti-neutrophil cytoplasmic autoantibody (ANCA)-associated vasculitis (granulomatosis with polyangiitis [GPA] and microscopic polyangiitis [MPA]) in combination with standard therapy including glucocorticoids. Tavneos does not eliminate glucocorticoid use.

This drug may have the following side effects:

• chest pain,
• headache,
• dizziness,
• vomiting,
• cough,
• sore throat,
• fever,
• tiredness,
• runny nose,
• hives, 
• difficulty breathing, 
• swelling of your face, lips, tongue, or throat, 
• fainting, 
• severe dizziness, 
• body aches,
• trouble swallowing,
• severe abdominal pain, 
• earache, 
• pain during urination, 
• cold sores, and
• red, warm, swollen or painful skin

The following drugs are related to Tavneos, either as a replacement or used together:

• Prednisolone (prednisolone tablets)
• Prelone (prednisolone (syrup))
• Prednisolone Oral Solution (prednisolone sodium phosphate oral solution)